Ability Pharmaceuticals is a drug discovery and development company.
Ability Pharmaceuticals has raised $7.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2024.
Ability Pharmaceuticals's investors include Inveready, European Innovation Council, Capital Cell, CTI Life Sciences Fund, SciClone Pharmaceuticals.
Ability Pharmaceuticals is headquartered in Barcelona, Spain.
Ability Pharmaceuticals is a drug discovery and development company.
Ability Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ability Pharmaceuticals — Funding & Investors." VCBacked, March 11, 2024, https://www.vcbacked.co/company/ability-pharmaceuticals. Accessed October 17, 2026.
VCBacked. (2024). Ability Pharmaceuticals — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/ability-pharmaceuticals
{{cite web |title=Ability Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/ability-pharmaceuticals |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated